Who invested in Ottimo Pharma

One round we have observed, with the 10 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$140Mraised across 1 round since 2024, from 2 sources

Latest round: Series A, $140MDec 2024
Led by: Avoro Capital
Investors: 10 (1 led)

See who backed them

The rounds

Dec 2024
Series A$140M
Reported by Firms' own news pages and 1 other

Funding filed with regulators

Ottimo Pharma filed 2 raises, $144M in all. Filings say how much was sold and to how many investors; they never name the investors.

Dec 2024$143MUK share allotment
Oct 2024$412KUK share allotment

Founders and team

From Ottimo Pharma's own website: 8 on the team.

David EpsteinChair & Chief Executive Officer
Mehdi ShahidiHead of Development & Chief Medical Officer
Spencer FiskChief Technical and Quality Officer
Julio GagneVP Business Development & Program Management
James SabryVice-Chair
Ling ZengGeneral Counsel and EVP of Execution
Samsara BioCapitalBoard Director
Susan SingerDirector of Executive Operations

AdvisersJonny Finlay

Everyone who backed them

Avoro CapitalInvestment firm1round, led 1

OrbiMedPrivate equity1round

JP MorganInvestment bank1round

Janus Henderson InvestorsPrivate equity1round

InvusPrivate equity1round

Samsara BioCapitalVC firm1round

RTW Investments LLCGrowth equity1round

Decheng CapitalVC firm1round

MedicxiVC firm1round

J.P. Morgan Life Sciences Private CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Ottimo Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Avoro Capital Advi...Private equityPer its own site

Quick answers about Ottimo Pharma

Who invested in Ottimo Pharma?

Ottimo Pharma's investors include Avoro Capital, OrbiMed, JP Morgan, Janus Henderson Investors and Invus, and 5 more on record. Avoro Capital led its latest round.